In lung cancer cells, p53 downregulates SLC7A11 expression to impede cellular cysteine uptake, resulting in diminished GPX4 activity and heightened vulnerability to ferroptosis [84] (Fig. 2). The gene discussed is GPX4; the disease is lung carcinoma.